CompaniesCorimmun

Corimmun

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

86

By Phase

PHASE2: 1PHASE1: 1

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
Today
NCT01391507
Hover over trial bars to see details

Recent Trials

NCT01391507Lead Sponsor
Pilot Study of COR-1 in Heart Failure
PHASE2Completed
36 participants
Started: Oct 31, 2011 · Completed: Aug 31, 2013
NCT01043146Lead Sponsor
Safety, Pharmacokinetic and Pharmacodynamic Study of COR-1, an Anti-ß1 Receptor Antibody Cyclopeptide
PHASE1Completed
50 participants
Started: Oct 31, 2009 · Completed: Jan 31, 2010
Related Companies
Janssen
acquired